ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00100672
Recruitment Status : Completed
First Posted : January 5, 2005
Last Update Posted : July 4, 2011
Sponsor:
Information provided by:
INSYS Therapeutics Inc

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2009
  Actual Study Completion Date : November 2010